SCHEMBL8767145

SCHEMBL8767145

COc1ccc(Cl)c(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)c3cnc(OC(=O)NCC(=O)O)c(OC)c3)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.47
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPT P10636 2/20 0.46
NLRP3 Q96P20 3/20 0.46
KMT2A Q03164 3/20 0.45
HTT P42858 1/20 0.45
MEN1 O00255 2/20 0.43
ABCC8 Q09428 2/20 0.43
ABCC3 O15438 1/20 0.43
ABCC4 O15439 1/20 0.43
ABCC9 O60706 1/20 0.43
ABCB11 O95342 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CFTR P13569 1/20 0.43
TSHR P16473 1/20 0.43
HTR2A P28223 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768265 0.93 LMNA (0.44) LMNAALDH1A1SMN1; SMN2MAPTNLRP3
SCHEMBL8768242 0.93 LMNA (0.47) LMNAALDH1A1SMN1; SMN2MAPTNLRP3
SCHEMBL8096976 0.92 ALDH1A1 (0.44) LMNAALDH1A1SMN1; SMN2MAPTNLRP3
SCHEMBL8915470 0.89 LMNA (0.49) LMNAALDH1A1SMN1; SMN2MAPTNLRP3
SCHEMBL8097619 0.85 ALDH1A1 (0.41) LMNAALDH1A1SMN1; SMN2MAPTNLRP3
SCHEMBL8868488 0.85 LMNA (0.51) LMNAALDH1A1SMN1; SMN2MAPTNLRP3
SCHEMBL8089693 0.84 ALDH1A1 (0.44) LMNAALDH1A1SMN1; SMN2MAPTNLRP3
SCHEMBL8917143 0.84 LMNA (0.49) LMNAALDH1A1SMN1; SMN2MAPTNLRP3
SCHEMBL8768266 0.84 ROCK2 (0.46) ALDH1A1MAPTNLRP3KMT2AMEN1
SCHEMBL8915243 0.84 LMNA (0.45) LMNAALDH1A1SMN1; SMN2MAPTNLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0673931-B1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AG (DE) 1997-08-13 EP disclosed
EP-0673931-A1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-27 EP disclosed